Skip to main content

Closed

ARCT: Arcturus Therapeutics Holdings Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-196.7%

ROIC-41.4%

Financially safe

Stretched

Debt / equity0.13×

Interest coverage0.0×

Current ratio6.31×

Arcturus Therapeutics Holdings Inc.

ARCTNASDAQ Global Market·USD·Closed

Arcturus Therapeutics Holdings Inc.

ARCTNASDAQ·USD·Closed

$5.76

−2.70%

$5.76

−$0.16 (2.70%)

52W Range

1thpctl

Volume

0.56×avg

Mkt Cap

163.72MUSD

P/E

-2.0TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.56×avg

Market Cap

163.72MUSD

P/E Ratio

-2.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings